Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.03
+0.03003.00%
Volume:59.61K
Turnover:60.81K
Market Cap:27.45M
PE:-3.61
High:1.06
Open:1.00
Low:1.00
Close:1.00
52wk High:3.40
52wk Low:0.7069
Shares:26.65M
Float Shares:21.83M
Volume Ratio:5.23
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.67
PE(LYR):-2.62

Loading ...

Mar 15, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 29, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 17, 2024

Correspondence

Form CORRESP - Correspondence
Feb 16, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Feb 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 12, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report